EPISODE · Mar 12, 2026 · 13 MIN
What's Next for Charles River?
from TD Cowen Insights · host TD Securities
Recorded on 03/03/26 There's no shortage of debates in the CRO space right now: the impact of regulatory changes, a potentially rebounding macro environment, and, most recently, the implications of AI. We're joined by Birgit Girshick, current Executive Vice President, Chief Operating Officer, and incoming CEO of Charles River Labs. We discuss her vision and key priorities for CRL, the biggest recent changes she's seen in the industry, the potential impact of AI, and where she sees the largest strategic opportunities. This episode was recorded at TD Cowen's 46th annual Health Care Conference. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
What this episode covers
Recorded on 03/03/26 There's no shortage of debates in the CRO space right now: the impact of regulatory changes, a potentially rebounding macro environment, and, most recently, the implications of AI. We're joined by Birgit Girshick, current Executive Vice President, Chief Operating Officer, and incoming CEO of Charles River Labs. We discuss her vision and key priorities for CRL, the biggest recent changes she's seen in the industry, the potential impact of AI, and where she sees the largest strategic opportunities. This episode was recorded at TD Cowen's 46th annual Health Care Conference.
NOW PLAYING
What's Next for Charles River?
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m